USA: Staying secure - FDA's evolving approach to medical device cybersecurity

As the introduction of new medical devices continues to become a major part of the US health care sector, the mitigation of cybersecurity risks to such devices is an area of increasing focus for the U.S. Food and Drug Administration (FDA).

Given the rate of technological advancement, the FDA has had to be equally fast-moving in developing its approach to medical device review processes and the issuance of new guidance. Yarmela Pavlovic and Shilpa Prem, of Hogan Lovells, discuss the major initiatives taken by the FDA in the last year to expand the knowledge base, and to provide stakeholders the information they need to increase the cybersecurity of their medical devices.

Read more: USA: Staying secure - FDA's evolving approach to medical device cybersecurity

Published here with permission from DataGuidance


Download PDF Share Back To Listing
Loading data